计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| O612556-5mg |
5mg |
期货 ![]() |
| |
| O612556-10mg |
10mg |
期货 ![]() |
| |
| O612556-25mg |
25mg |
期货 ![]() |
| |
| O612556-50mg |
50mg |
期货 ![]() |
| |
| O612556-100mg |
100mg |
期货 ![]() |
|
| 别名 | 邻甲苯海明 | 奥芬那君 | 奥芬那君 |
|---|---|
| 英文别名 | Orfenadrina | Orphenadinum | Disipal | Invagesic | o-Monomethyldiphenhydramine | o-Methyldiphenhydramine | Orphenedrine | Brocadisipal | Orphenadrinum | Mefenamine | (±)-Orphenadrine | 2-Methyldiphenhydramine |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Orphenadrine |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 拮抗剂 |
| 产品介绍 |
Orphenadrine ((±)-Orphenadrine) 是一种骨骼肌松弛剂和 NMDA 拮抗剂 。Orphenadrine 能够抑制剂 [3H]MK-801 与 NMDA 受体的苯环己哌啶 (PCP) 结合位点的结合。Orphenadrine 还是抗胆碱能剂和细胞色素 P450 (CYP) 2B 诱导剂。Orphenadrine 可能发挥促肿瘤作用,导致 CAR 核易位,导致微粒体活性氧 (ROS) 的产生和氧化应激。Orphenadrine 还发挥神经细胞保护作用,可保护大鼠小脑颗粒细胞 (CGC) 免受 3-NPA 诱导的死亡,对 NMDA 受体过度激活介导的神经退行性疾病有抑制潜力。固态 Orphenadrine ((±)-Orphenadrine) is a skeletal muscle relaxant and NMDA antagonist . Orphenadrine inhibits the binding of [3H]MK-801 to the phencyclidine (PCP) binding site of the NMDA receptor. Orphenadrine is also an anticholinergic and cytochrome P450 (CYP) 2B inducer. Orphenadrine may exert pro-tumor effects, causing CAR nuclear translocation, resulting in microsomal reactive oxygen species (ROS) production and oxidative stress. Orphenadrine also exerts neuronal protection, protecting rat cerebellar granule cells (CGC) from 3-NPA-induced death and has inhibitory potential against neurodegenerative diseases mediated by NMDA receptor overactivation . |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine |
| INCHI | 1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3 |
| InChi Key | QVYRGXJJSLMXQH-UHFFFAOYSA-N |
| Smiles | CN(CCOC(c1ccccc1C)c1ccccc1)C |
| Isomeric SMILES | CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C |
| PubChem CID | 4601 |
| 分子量 | 269.38 |
| 分子量 | 269.400 g/mol |
|---|---|
| XLogP3 | 3.800 |
| 氢键供体数Hydrogen Bond Donor Count | 0 |
| 氢键受体数Hydrogen Bond Acceptor Count | 2 |
| 可旋转键计数Rotatable Bond Count | 6 |
| 精确质量Exact Mass | 269.178 Da |
| 单同位素质量Monoisotopic Mass | 269.178 Da |
| 拓扑极表面积Topological Polar Surface Area | 12.500 Ų |
| 重原子数Heavy Atom Count | 20 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 260.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 1 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Yanru Liu, Xia Wang, Jia Yu, Xingjie Guo. (2021) Chiral separation and molecular simulation study of six antihistamine agents on a coated cellulose tri-(3,5-dimethylphenycarbamate) column (Chiralcel OD-RH) and its recognition mechanisms. ELECTROPHORESIS, 42 (14-15): (1461-1472). [PMID:33905565] [10.1002/elps.202100033] |